REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,456 | +14.2% | 700,000 | 0.0% | 0.36% | +57.8% |
| Q2 2023 | $7,406 | +7.5% | 700,000 | 0.0% | 0.23% | -43.8% |
| Q1 2023 | $6,888 | -33.1% | 700,000 | 0.0% | 0.41% | -28.9% |
| Q4 2022 | $10,297 | -99.9% | 700,000 | 0.0% | 0.58% | +58.8% |
| Q3 2022 | $8,491,000 | -13.3% | 700,000 | 0.0% | 0.36% | -30.8% |
| Q2 2022 | $9,793,000 | -1.8% | 700,000 | 0.0% | 0.52% | +25.4% |
| Q1 2022 | $9,968,000 | -32.5% | 700,000 | 0.0% | 0.42% | +4.0% |
| Q4 2021 | $14,763,000 | +2.3% | 700,000 | +27.3% | 0.40% | +24.1% |
| Q3 2021 | $14,432,000 | -15.8% | 550,000 | 0.0% | 0.32% | -7.2% |
| Q2 2021 | $17,149,000 | +1.6% | 550,000 | 0.0% | 0.35% | +16.8% |
| Q1 2021 | $16,880,000 | -13.7% | 550,000 | -3.5% | 0.30% | -29.0% |
| Q4 2020 | $19,551,000 | +11.5% | 570,000 | 0.0% | 0.42% | -1.4% |
| Q3 2020 | $17,539,000 | -5.8% | 570,000 | -5.0% | 0.43% | -18.2% |
| Q2 2020 | $18,612,000 | – | 600,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $22,067,538 | 9.20% |
| CHI Advisors LLC | 2,997,939 | $29,499,719 | 7.83% |
| MPM BioImpact LLC | 1,639,849 | $16,136,114 | 4.19% |
| BVF INC/IL | 8,291,988 | $81,593,162 | 2.98% |
| HighVista Strategies LLC | 164,890 | $1,622,518 | 1.32% |
| Sio Capital Management, LLC | 228,538 | $2,248,814 | 1.11% |
| Deep Track Capital, LP | 2,727,606 | $26,839,643 | 1.10% |
| Redmile Group, LLC | 2,533,050 | $24,925,212 | 1.08% |
| Orbimed Advisors | 3,322,488 | $32,693,282 | 0.64% |
| Artal Group S.A. | 700,000 | $6,888 | 0.41% |